China Resources Double-Crane Pharmaceutical Co.,Ltd. Share Price
Stocks
600062
CNE000000Q94
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
06/11/2026
|
5-day change | 1st Jan Change | ||
| 16.07 CNY | -0.19% |
|
+5.93% | -12.14% |
| 10:56am | CR Double-Crane Pharmaceutical Passes Drug GMP Compliance Inspection | MT |
| 04/11 | CR Double-Crane Pharmaceutical Gets Registration Certificates for Three Drugs | MT |
| Market Cap | 1.66TCr 248.78Cr 221.69Cr 202.77Cr 184.67Cr 348.09Cr 24TCr 357.47Cr 2.44TCr 974.1Cr 12TCr 933.8Cr 913.75Cr 39TCr | P/E 2026 * |
9.89x | P/E 2027 * | 9.24x |
|---|---|---|---|---|---|
| Enterprise Value | 1.66TCr 248.78Cr 221.69Cr 202.77Cr 184.67Cr 348.09Cr 24TCr 357.47Cr 2.44TCr 974.1Cr 12TCr 933.8Cr 913.75Cr 39TCr | EV / Sales 2026 * |
1.53x | EV / Sales 2027 * | 1.45x |
| Free-Float |
37.31% | Yield 2026 * |
2.86% | Yield 2027 * | 2.99% |
| 1 day | -0.19% | ||
| 1 week | +5.93% | ||
| Current month | +4.42% | ||
| 1 month | -1.05% | ||
| 3 months | -0.68% | ||
| 6 months | -9.97% | ||
| Current year | -12.14% |
| 1 week | 15.34 |  | 16.34 |
| 1 month | 15.03 | | 16.66 |
| Current year | 15.03 | | 19.08 |
| 1 year | 15.03 | | 19.77 |
| 3 years | 15.03 | | 26.15 |
| 5 years | 11.29 | | 37.44 |
| 10 years | 10.66 | | 37.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wen Hao Huang
DFI | Director of Finance/CFO | 43 | 18/02/2025 |
Qian Zhao
PSD | President | 45 | 25/10/2024 |
Li Hong Zheng
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ning Liu
BRD | Director/Board Member | 68 | 30/05/2006 |
Mao Zhu Sun
BRD | Director/Board Member | 67 | 12/07/2021 |
Shu Tian Yu
BRD | Director/Board Member | 60 | 10/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/12/22 | Buy | Chairman | 5,000 | 0.0005% | ||
| 21/12/22 | Buy | Director | 10,000 | 0.0010% | ||
| 20/12/22 | Buy | Director | 5,000 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.19% | +5.93% | -16.48% | -2.67% | 249.24Cr | |
| -0.14% | -3.84% | +45.41% | +129.03% | 1,21600Cr | |
| +0.24% | -0.25% | +45.76% | +79.65% | 66TCr | |
| +0.36% | -2.00% | +31.93% | +104.66% | 51TCr | |
| -0.89% | -3.79% | +46.34% | +63.65% | 38TCr | |
| -0.34% | -1.97% | +70.87% | +40.47% | 36TCr | |
| -0.98% | -0.52% | +30.57% | +57.98% | 31TCr | |
| -0.89% | -0.26% | +8.49% | +35.50% | 29TCr | |
| +0.20% | -0.95% | +46.25% | +69.18% | 25TCr | |
| +0.02% | -1.87% | +35.72% | +106.41% | 21TCr | |
| Average | -0.26% | +0.78% | +34.49% | +68.39% | 41.9TCr | |
| Weighted average by Cap. | -0.21% | +0.04% | +41.96% | +88.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.09TCr 162.89Cr 145.15Cr 132.76Cr 120.91Cr 227.91Cr 15TCr 234.06Cr 1.59TCr 637.79Cr 8.15TCr 611.41Cr 598.28Cr 26TCr | 1.14TCr 171.56Cr 152.88Cr 139.83Cr 127.35Cr 240.05Cr 16TCr 246.52Cr 1.68TCr 671.75Cr 8.59TCr 643.95Cr 630.13Cr 27TCr |
| Net income | 168.7Cr 25Cr 23Cr 21Cr 19Cr 35Cr 2.39TCr 36Cr 247.61Cr 99Cr 1.27TCr 95Cr 93Cr 3.99TCr | 180.55Cr 27Cr 24Cr 22Cr 20Cr 38Cr 2.56TCr 39Cr 265Cr 105.97Cr 1.35TCr 101.58Cr 99Cr 4.27TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | CN¥16.07 | -0.19% | 46,40,216 |
| 05/26/05 | CN¥16.10 | -0.19% | 63,46,646 |
| 04/26/04 | CN¥16.13 | +0.25% | 1,08,63,700 |
| 03/26/03 | CN¥16.09 | +2.55% | 1,02,78,764 |
| 02/26/02 | CN¥15.69 | +1.95% | 1,00,05,532 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600062 Stock
Select your edition
All financial news and data tailored to specific country editions
